by Pill Pals | Mar 17, 2025 | News
Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Mr. Charles D. Boyd Recipient Title Founder and Chief Executive Officer Safe Chain Solutions, LLC 822 Chesapeake DriveCambridge, MD 21613-9408United States Issuing Office: Division of Pharmaceutical...
by Pill Pals | Mar 17, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: North Carolina State University, Raleigh, North Carolina, USA (D.F.M....
by Pill Pals | Mar 17, 2025 | News
Reference #: FEI 3009728473 Product: Drugs Recipient: Recipient Name Amanda Biggart and Dakota Flowers Recipient Title Chief Operating Officer/Compliance Manager Safe Chain Solutions, LLC 822 Chesapeake DrCambridge, MD 21613-9408United States 855-437-5727...
by Pill Pals | Mar 17, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Universidad Iberoamericana, Santo Domingo, Dominican Republic (R....
by Pill Pals | Mar 17, 2025 | News
Delivery Method: Via Electronic Mail – Delivery and Read Receipt Requested Product: Drugs Recipient: Recipient Name Mr. Mark L’Hommedieu Recipient Title Managing Partner ProRx, LLC 619 Jeffers CircleExton, PA 19341-2540United States Issuing Office: Center for...
by Pill Pals | Mar 17, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Environmental Health National Referral Laboratory, Directorate General of...
by Pill Pals | Mar 17, 2025 | News
December 4, 2024 NCTR Uncovers Drug Interaction with UGT Enzymes as an Indicator of Drug-Induced Liver Injury Researchers at FDA’s National Center for Toxicological Research (NCTR), collaborating with scientists from Elsevier’s Life Sciences, conducted a study to...
by Pill Pals | Mar 17, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: School of Medicine and Biomedical Sciences, University of Porto, Porto,...
by Pill Pals | Mar 17, 2025 | News
April 9-10: SBIA | Generic Drugs Forum (GDF) 2025See the Agenda and Register Today!Get the latest on the development and approval of safe, effective, and high-quality generic medicines. FDA subject matter experts from every aspect of the pre-ANDA and ANDA assessment...